ClinicalTrials.Veeva

Menu

An Eye Tracking Study of Affective Disorder Patients With Suicide Risk

C

Central South University

Status

Unknown

Conditions

Major Depressive Disorder
Bipolar Disorder
Suicide

Treatments

Behavioral: eye-tracking

Study type

Observational

Funder types

Other

Identifiers

NCT03711045
Second Xiangya hospital CSU
Mental Health Insititute (Other Identifier)

Details and patient eligibility

About

This research tries to investigate the validity and reliability of eye-tracking technologies by using different paradigms (eg. free-view, pro-saccade and anti-saccade) which served as a novel way of evaluating suicide risk among affective disorder patients including bipolar and unipolar depression. All the participants including health control will be assessed by clinical interviewing, self-report assessment, cognitive evaluation and eye-tracking task.

Enrollment

200 estimated patients

Sex

All

Ages

12 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Diagnostic and Statistical Manual,DSM-IV diagnosis of depression or Bipolar disorder
  • BDI-II>20(Suicide and disorder control group); BDI-II<13,no history of depression(Health control)
  • Informed consent
  • suicide attempt in the past 6 months(suicide risk group)

Exclusion criteria

  • Current or past substance abuse, psychotic disorder,obsessive compulsive disorder , Post-Traumatic Stress Disorder, in the past 6 months
  • History of epilepsy or head trauma
  • Eye disorders
  • History of electroconvulsive therapy in the past 4 weeks.

Trial design

200 participants in 3 patient groups

Suicide Risk Group
Description:
patients with affective disorders(eg. bipolar disorder, major depression disorder) also have a history of suicide attempt in the past 6 months.
Treatment:
Behavioral: eye-tracking
Disorder Control Group
Description:
patients with affective disorders(eg. bipolar disorder, major depression disorder) and without suicide ideation or behavior.
Treatment:
Behavioral: eye-tracking
Healthy Control Group
Treatment:
Behavioral: eye-tracking

Trial contacts and locations

1

Loading...

Central trial contact

Li Lingjiang, MD Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems